Literature DB >> 24398797

Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.

Stephan Lobitz1, Claudia Frömmel2, Annemarie Brose2, Jeannette Klein3, Oliver Blankenstein3.   

Abstract

Sickle cell disease (SCD) does not occur in the indigenous German population. However, with the increasing numbers of immigrants its prevalence is steadily rising. Nevertheless, robust epidemiological data is not available for Germany and, consequently, the German newborn screening (NBS) program does not include SCD. Between 1 September 2011 and 30 November 2012, an unselected cohort of 34,084 Berlin newborns was tested for SCD. The results of 14 newborns were consistent with SCD and 265 babies were identified as hemoglobin S (Hb S) carriers. These data indicate a 95% probability that the incidence of SCD in Berlin is at least 2.5/10,000.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398797      PMCID: PMC4350602          DOI: 10.1038/ejhg.2013.286

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality.

Authors:  Scott D Grosse; Hani K Atrash; Isaac Odame; Djesika Amendah; Frédéric B Piel; Thomas N Williams
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

2.  Implementing neonatal screening for haemoglobinopathies in the Netherlands.

Authors:  Marelle J Bouva; Karin Mohrmann; Henri B J M Brinkman; Evelien A Kemper-Proper; Bert Elvers; J Gerard Loeber; Francesco E A M Verheul; Piero C Giordano
Journal:  J Med Screen       Date:  2010       Impact factor: 2.136

3.  Potential of the Sebia Capillarys neonat fast automated system for neonatal screening of sickle cell disease.

Authors:  Gilles Renom; Claude Mereau; Patrice Maboudou; Jean-Marc Périni
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

4.  An evaluation of the Sebia capillarys Neonat Haemoglobin FAST™ system for routine newborn screening for sickle cell disease.

Authors:  C Murray; S K Hall; P Griffiths
Journal:  Int J Lab Hematol       Date:  2011-05-03       Impact factor: 2.877

5.  Neonatal screening for metabolic and endocrine disorders.

Authors:  Erik Harms; Bernhard Olgemöller
Journal:  Dtsch Arztebl Int       Date:  2011-01-10       Impact factor: 5.594

6.  Hemoglobinopathies: a longitudinal study over four decades.

Authors:  Elisabeth Kohne; Enno Kleihauer
Journal:  Dtsch Arztebl Int       Date:  2010-02-05       Impact factor: 5.594

7.  Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Authors:  Natasha B Halasa; Sadhna M Shankar; Thomas R Talbot; Patrick G Arbogast; Ed F Mitchel; Winfred C Wang; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

8.  Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.

Authors:  Thomas V Adamkiewicz; Sharada Sarnaik; George R Buchanan; Rathi V Iyer; Scott T Miller; Charles H Pegelow; Zora R Rogers; Elliott Vichinsky; John Elliott; Richard R Facklam; Katherine L O'Brien; Benjamin Schwartz; Chris A Van Beneden; Michael J Cannon; James R Eckman; Harry Keyserling; Kevin Sullivan; Wing-Yen Wong; Winfred C Wang
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

9.  Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.

Authors:  Thomas V Adamkiewicz; Benjamin J Silk; James Howgate; Wendy Baughman; Gregory Strayhorn; Kevin Sullivan; Monica M Farley
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival.

Authors:  D Powars; G Overturf; J Weiss; S Lee; L Chan
Journal:  JAMA       Date:  1981-05-08       Impact factor: 56.272

View more
  2 in total

1.  Neonatal Screening for Congenital Metabolic and Endocrine Disorders–Results From Germany for the Years 2006–2018.

Authors:  Anja Lüders; Oliver Blankenstein; Inken Brockow; Regina Ensenauer; Martin Lindner; Andreas Schulze; Uta Nennstiel
Journal:  Dtsch Arztebl Int       Date:  2021-02-19       Impact factor: 5.594

2.  Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants.

Authors:  Claudia Frömmel; Annemarie Brose; Jeannette Klein; Oliver Blankenstein; Stephan Lobitz
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.